中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 11
Nov.  2014
Turn off MathJax
Article Contents

Analysis of clinical characteristics of viral hepatitis in pregnant women

DOI: 10.3969/j.issn.1001-5256.2014.11.021
Research funding:

 

  • Received Date: 2014-06-24
  • Published Date: 2014-11-20
  • Objective To study the clinical characteristics of viral hepatitis in pregnancy. Methods A retrospective analysis was performed on 77 pregnant women with viral hepatitis who were admitted to our hospital from January 2009 to March 2013. Cause of hepatitis, serologic and virologic markers, degree of liver damage, and association with the stage of pregnancy were analyzed. Comparison of continuous data between groups was made by Kruskal- Wallis H test. Results The main cause of viral hepatitis in pregnancy was HBV infection (72cases, 93. 51%) , and 10. 27% of patients were infected with hepatitis A, B or E virus. Moderate liver damage was detected in 64 patients (83.12%) , severe liver damage in 7 patients (9.09%) , and liver failure in 3 patients (3.90%) . Sixteen patients (20.78%) were diagnosed with hepatitis in the first trimester of pregnancy, 49 (63. 64%) in the second trimester, and 12 (15. 58%) in the third trimester.Liver function indices, including total bile acid (TBA) , total bilirubin (TBil) , albumin ( Alb) , alanine aminotransferase ( ALT) , aspartate transaminase (AST) , and prothrombin activity (PTA) , were compared between HBeAg ( +) and HBeAg (-) patients and between patients with HBV DNA > 106 IU /ml and ≤106IU /ml, and no significant differences were found in either comparison (P > 0. 05) . Conclusion Viral hepatitis in pregnancy is mainly caused by infection with hepatitis B virus. Liver damage is mostly moderate and severe liver damage and liver failure often occur in the middle or late stage of pregnancy. This study indicates that pregnant women should take precautions and active treatment for chronic hepatitis B.

     

  • loading
  • [1] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].Chin J Infect Dis, 2011, 39 (2) :65-80. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].中华传染病杂志, 2011, 39 (2) :65-80.
    [2]YANG SJ, REN H.Infectious diseases[M].7th ed.Beijing:People's Medical Publishing House, 2008:23-51. (in Chinese) 杨绍基, 任红.传染病学[M].7版.北京:人民卫生出版社, 2008:23-51.
    [3]SHAO MM, LI P, QIAN Y, et al.Detection of hepatitis B virus in pregnant women[J].Chin J Birth Health Heredity, 2006, 14 (5) :82. (in Chinese) 邵明明, 李萍, 钱燕, 等.孕妇乙肝病毒检测分析[J].中国优生与遗传杂志, 2006, 14 (5) :82.
    [4] YOU Y, XING AY, ZHOU YB, et al.Hepatitis B virus infection in pregnant women:an investigation of 5361 cases[J].J Chin Mod Gynecol Obstetr, 2004, 1 (1) :85-86. (in Chinese) 游泳, 邢爱耘, 周永碧, 等.孕妇乙型肝炎病毒感染5361例情况调查[J].中华现代妇产科学杂志, 2004, 1 (1) :85-86.
    [5]PENG J, HOU JL.Current status and management of pregnancy and anti-HBV therapy[J].Chin J Hepatol, 2011, 19 (3) :236-238. (in Chinese) 彭劼, 侯金林.妊娠与抗乙型肝炎病毒治疗的现状与管理[J].中华肝脏病杂志, 2011, 19 (3) :236-238.
    [6]LONG ZH, ZHUO SH.Etiology and impact of viral hepatitis in pregnant women[J].Guangzhou Med J, 2007, 38 (3) :45-47. (in Chinese) 龙昭华, 卓树洪.妊娠合并病毒性肝炎的病原学及其对妊娠的影响[J].广州医药, 2007, 38 (3) :45-47.
    [7]WANG GJ, HAN GR, YU MM, et al.Analysis of maternal and fetal outcome in late pregnancy with severe liver diseases[J].Jiangsu Med J, 2010, 36 (16) :1952-1953. (in Chinese) 王根菊, 韩国荣, 余敏敏, 等.晚期妊娠合并重症肝病的母婴结局分析[J].江苏医药, 2010, 36 (16) :1952-1953.
    [8]WANG GJ, HAN GR, YU MM.Clinical analysis of 14 pregnant women with severe liver diseases[J].J Southeast Univ:Med Sci Edi, 2008, 27 (6) :443-445. (in Chinese) 王根菊, 韩国荣, 余敏敏.14例妊娠合并重症肝病临床分析[J].东南大学学报:医学版, 2008, 27 (6) :443-445.
    [9]HAN GR, JIANG HX, WANG GJ, et al.Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus[J].Chin J Infect Dis, 2012, 20 (3) :201-205. (in Chinese) 韩国荣, 江红秀, 王根菊, 等.替比夫定对乙型肝炎病毒高载量孕妇母婴传播的阻断效果及其安全性[J].中华传染病杂志, 2012, 20 (3) :201-205.
    [10]ZHU MQ, HUANG XY, JIANG JN, et al.Efficacy and safety of lamivudine for preventing mother-to-child transmission of hepatitis B virus:a systematic review[J].Chin Hepatol, 2012, 17 (2) :99-103. (in Chinese) 祝美琴, 黄晓云, 江建宁, 等.拉米夫定阻断HBV母婴传播疗效及安全性的系统评价[J].肝脏, 2012, 17 (2) :99-103.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2739) PDF downloads(672) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return